Short Interest in bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Decreases By 39.1%

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totaling 691 shares, a decline of 39.1% from the June 30th total of 1,134 shares. Based on an average daily volume of 614 shares, the days-to-cover ratio is presently 1.1 days.

bioAffinity Technologies Stock Performance

Shares of BIAFW opened at $0.09 on Friday. The business has a fifty day moving average of $0.14 and a 200 day moving average of $0.24. bioAffinity Technologies has a 52-week low of $0.05 and a 52-week high of $0.81.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.

In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.